Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial (Q33412064)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial |
scientific article |
Statements
1 reference
Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial (English)
1 reference
William G Wierda
1 reference
Susan O'Brien
1 reference
John C Byrd
1 reference
Nyla A Heerema
1 reference
Weiqiang Zhao
1 reference
Steven E Coutre
1 reference
Fong Clow
1 reference
Danelle F James
1 reference
Kristie A Blum
1 reference
Jeff P Sharman
1 reference
Raquel Izumi
1 reference
Jan A Burger
1 reference
Jeffrey A Jones
1 reference
Richard R Furman
1 reference
Barbara Grant
1 reference
Donald A Richards
1 reference
Morton Coleman
1 reference
Amy J Johnson
1 reference
Ahmed Hamdy
1 reference
Betty Y Chang
1 reference
Thorsten Graef
1 reference
Joseph J Buggy
1 reference
10 December 2013
1 reference
1 reference
Identifiers
1 reference